The purpose of this study is to determine whether the ANGPTL4 E40K and T266M polymorphisms are associated with triglyceride levels in well characterized patients with T2D, and with CVD risk factors, such as metabolic syndrome and obesity in type 2 diabetic Tunisian population. The gene discussed is ANGPTL4; the disease is obesity disorder.